Titre : Motifs EF Hands

Motifs EF Hands : Questions médicales fréquentes

Termes MeSH sélectionnés :

Enterococcus faecium
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Motifs EF Hands : Questions médicales les plus fréquentes", "headline": "Motifs EF Hands : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Motifs EF Hands : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-19", "dateModified": "2025-03-14", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Motifs EF Hands" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Motifs à hélice-boucle-hélice", "url": "https://questionsmedicales.fr/mesh/D018257", "about": { "@type": "MedicalCondition", "name": "Motifs à hélice-boucle-hélice", "code": { "@type": "MedicalCode", "code": "D018257", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G02.111.570.820.709.275.500.360" } } }, "about": { "@type": "MedicalCondition", "name": "Motifs EF Hands", "alternateName": "EF Hand Motifs", "code": { "@type": "MedicalCode", "code": "D020832", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Peter B Stathopulos", "url": "https://questionsmedicales.fr/author/Peter%20B%20Stathopulos", "affiliation": { "@type": "Organization", "name": "Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada." } }, { "@type": "Person", "name": "Qi-Tong Lin", "url": "https://questionsmedicales.fr/author/Qi-Tong%20Lin", "affiliation": { "@type": "Organization", "name": "Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada." } }, { "@type": "Person", "name": "Biraj B Kayastha", "url": "https://questionsmedicales.fr/author/Biraj%20B%20Kayastha", "affiliation": { "@type": "Organization", "name": "Department of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, OK, 74078, USA." } }, { "@type": "Person", "name": "Aya Kubo", "url": "https://questionsmedicales.fr/author/Aya%20Kubo", "affiliation": { "@type": "Organization", "name": "Department of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, OK, 74078, USA." } }, { "@type": "Person", "name": "Jacob Burch-Konda", "url": "https://questionsmedicales.fr/author/Jacob%20Burch-Konda", "affiliation": { "@type": "Organization", "name": "Department of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, OK, 74078, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Development of a workflow for the detection of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis from rectal swabs using the spectra VRE medium.", "datePublished": "2023-01-06", "url": "https://questionsmedicales.fr/article/36609280", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12941-023-00552-8" } }, { "@type": "ScholarlyArticle", "name": "In vitro activity and adaptation strategies of eravacycline in clinical Enterococcus faecium isolates from China.", "datePublished": "2022-07-27", "url": "https://questionsmedicales.fr/article/35896611", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41429-022-00546-2" } }, { "@type": "ScholarlyArticle", "name": "Anticancer Effect of Enterococcus faecium, Isolated from Vaginal Fluid, on Ovarian Cancer Cells", "datePublished": "2023-07-01", "url": "https://questionsmedicales.fr/article/37525437", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.52547/ibj.3846" } }, { "@type": "ScholarlyArticle", "name": "Efficacy of teicoplanin in bloodstream infections caused by Enterococcus faecium: posthoc analysis of a nationwide surveillance.", "datePublished": "2022-06-23", "url": "https://questionsmedicales.fr/article/35752376", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ijid.2022.06.029" } }, { "@type": "ScholarlyArticle", "name": "Dissemination of Quinupristin-Dalfopristin and Linezolid resistance genes among hospital environmental and healthy volunteer fecal isolates of Enterococcus faecalis and Enterococcus faecium.", "datePublished": "2022-06-18", "url": "https://questionsmedicales.fr/article/35716285", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11033-022-07627-3" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Phénomènes chimiques", "item": "https://questionsmedicales.fr/mesh/D055598" }, { "@type": "ListItem", "position": 3, "name": "Phénomènes biochimiques", "item": "https://questionsmedicales.fr/mesh/D001669" }, { "@type": "ListItem", "position": 4, "name": "Conformation moléculaire", "item": "https://questionsmedicales.fr/mesh/D008968" }, { "@type": "ListItem", "position": 5, "name": "Conformation des protéines", "item": "https://questionsmedicales.fr/mesh/D011487" }, { "@type": "ListItem", "position": 6, "name": "Éléments structuraux des protéines", "item": "https://questionsmedicales.fr/mesh/D000072416" }, { "@type": "ListItem", "position": 7, "name": "Motifs à hélice-boucle-hélice", "item": "https://questionsmedicales.fr/mesh/D018257" }, { "@type": "ListItem", "position": 8, "name": "Motifs EF Hands", "item": "https://questionsmedicales.fr/mesh/D020832" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Motifs EF Hands - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Motifs EF Hands", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-06", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Motifs EF Hands", "description": "Comment diagnostiquer un motif EF Hand ?\nQuels tests sont utilisés pour les motifs EF Hands ?\nLes motifs EF Hands sont-ils visibles par imagerie ?\nPeut-on identifier des mutations dans les motifs EF Hands ?\nQuel rôle joue la bioinformatique dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D020832?mesh_terms=Enterococcus+faecium&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Motifs EF Hands", "description": "Quels symptômes sont associés aux motifs EF Hands ?\nLes motifs EF Hands sont-ils liés à des maladies ?\nComment les motifs EF Hands affectent-ils la signalisation cellulaire ?\nY a-t-il des signes cliniques de dysfonction des motifs EF Hands ?\nLes motifs EF Hands influencent-ils le métabolisme ?", "url": "https://questionsmedicales.fr/mesh/D020832?mesh_terms=Enterococcus+faecium&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Motifs EF Hands", "description": "Peut-on prévenir les anomalies des motifs EF Hands ?\nY a-t-il des facteurs environnementaux à considérer ?\nComment le stress influence-t-il les motifs EF Hands ?\nL'exercice physique a-t-il un impact sur ces motifs ?\nLes suppléments de calcium sont-ils bénéfiques ?", "url": "https://questionsmedicales.fr/mesh/D020832?mesh_terms=Enterococcus+faecium&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Motifs EF Hands", "description": "Quels traitements ciblent les motifs EF Hands ?\nPeut-on modifier les motifs EF Hands par thérapie génique ?\nLes médicaments peuvent-ils influencer les motifs EF Hands ?\nY a-t-il des approches expérimentales pour traiter les anomalies ?\nComment la nutrition peut-elle influencer les motifs EF Hands ?", "url": "https://questionsmedicales.fr/mesh/D020832?mesh_terms=Enterococcus+faecium&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Motifs EF Hands", "description": "Quelles complications peuvent survenir avec des motifs EF Hands défectueux ?\nLes motifs EF Hands sont-ils liés à des cancers ?\nComment les complications affectent-elles la qualité de vie ?\nY a-t-il des risques de maladies cardiovasculaires ?\nLes complications sont-elles réversibles ?", "url": "https://questionsmedicales.fr/mesh/D020832?mesh_terms=Enterococcus+faecium&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Motifs EF Hands", "description": "Quels sont les facteurs de risque pour les anomalies des motifs EF Hands ?\nL'âge influence-t-il les motifs EF Hands ?\nLe mode de vie joue-t-il un rôle dans les risques ?\nLes antécédents familiaux sont-ils un facteur de risque ?\nLes infections peuvent-elles affecter les motifs EF Hands ?", "url": "https://questionsmedicales.fr/mesh/D020832?mesh_terms=Enterococcus+faecium&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer un motif EF Hand ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des analyses biochimiques et des études de structure protéique." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour les motifs EF Hands ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des techniques comme la spectroscopie RMN et la cristallographie aux rayons X sont utilisées." } }, { "@type": "Question", "name": "Les motifs EF Hands sont-ils visibles par imagerie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Non, ils nécessitent des méthodes biochimiques pour être étudiés, pas d'imagerie classique." } }, { "@type": "Question", "name": "Peut-on identifier des mutations dans les motifs EF Hands ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des techniques de séquençage génétique peuvent révéler des mutations affectant ces motifs." } }, { "@type": "Question", "name": "Quel rôle joue la bioinformatique dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "La bioinformatique aide à prédire la structure et la fonction des motifs EF Hands." } }, { "@type": "Question", "name": "Quels symptômes sont associés aux motifs EF Hands ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les motifs EF Hands ne présentent pas de symptômes directs, mais affectent des fonctions cellulaires." } }, { "@type": "Question", "name": "Les motifs EF Hands sont-ils liés à des maladies ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies dans ces motifs peuvent être associées à des maladies comme l'ataxie." } }, { "@type": "Question", "name": "Comment les motifs EF Hands affectent-ils la signalisation cellulaire ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Ils régulent la signalisation calcique, influençant divers processus cellulaires." } }, { "@type": "Question", "name": "Y a-t-il des signes cliniques de dysfonction des motifs EF Hands ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des signes indirects peuvent apparaître, comme des troubles neurologiques ou musculaires." } }, { "@type": "Question", "name": "Les motifs EF Hands influencent-ils le métabolisme ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils jouent un rôle dans le métabolisme cellulaire en régulant le calcium." } }, { "@type": "Question", "name": "Peut-on prévenir les anomalies des motifs EF Hands ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention est difficile, mais un mode de vie sain peut réduire les risques associés." } }, { "@type": "Question", "name": "Y a-t-il des facteurs environnementaux à considérer ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des toxines peut affecter la fonction des motifs EF Hands." } }, { "@type": "Question", "name": "Comment le stress influence-t-il les motifs EF Hands ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Le stress peut perturber la signalisation calcique, affectant indirectement ces motifs." } }, { "@type": "Question", "name": "L'exercice physique a-t-il un impact sur ces motifs ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "L'exercice régule la signalisation calcique, ce qui peut soutenir la fonction des motifs." } }, { "@type": "Question", "name": "Les suppléments de calcium sont-ils bénéfiques ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Des suppléments peuvent aider à maintenir un bon équilibre calcique, soutenant la fonction." } }, { "@type": "Question", "name": "Quels traitements ciblent les motifs EF Hands ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de traitements spécifiques pour les motifs EF Hands." } }, { "@type": "Question", "name": "Peut-on modifier les motifs EF Hands par thérapie génique ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie génique pourrait potentiellement corriger des mutations affectant ces motifs." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils influencer les motifs EF Hands ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments modulent la signalisation calcique, indirectement affectant ces motifs." } }, { "@type": "Question", "name": "Y a-t-il des approches expérimentales pour traiter les anomalies ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des recherches sont en cours sur des peptides et des inhibiteurs ciblant les motifs EF Hands." } }, { "@type": "Question", "name": "Comment la nutrition peut-elle influencer les motifs EF Hands ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Une nutrition adéquate en calcium et en magnésium peut soutenir leur fonction." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des motifs EF Hands défectueux ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications peuvent inclure des troubles neurologiques et musculaires." } }, { "@type": "Question", "name": "Les motifs EF Hands sont-ils liés à des cancers ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Des études suggèrent un lien potentiel entre des anomalies et certains types de cancer." } }, { "@type": "Question", "name": "Comment les complications affectent-elles la qualité de vie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent entraîner des limitations fonctionnelles et des douleurs chroniques." } }, { "@type": "Question", "name": "Y a-t-il des risques de maladies cardiovasculaires ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Des dysfonctionnements calciques peuvent contribuer à des maladies cardiovasculaires." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les anomalies des motifs EF Hands ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des prédispositions génétiques et des expositions environnementales." } }, { "@type": "Question", "name": "L'âge influence-t-il les motifs EF Hands ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le vieillissement peut affecter la fonction des motifs EF Hands et la signalisation calcique." } }, { "@type": "Question", "name": "Le mode de vie joue-t-il un rôle dans les risques ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sédentaire et une mauvaise alimentation augmentent les risques." } }, { "@type": "Question", "name": "Les antécédents familiaux sont-ils un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de maladies génétiques peuvent augmenter le risque." } }, { "@type": "Question", "name": "Les infections peuvent-elles affecter les motifs EF Hands ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Certaines infections peuvent perturber la signalisation calcique, affectant ces motifs." } } ] } ] }

Sources (536 au total)

Development of a workflow for the detection of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis from rectal swabs using the spectra VRE medium.

Spectra™ VRE agar (Remel, Lenexa, KS) is a chromogenic agar that is FDA approved for screening patients for VRE colonization. The package insert recommends confirming isolates with identification and ... Our laboratory sought to develop a workflow to optimize the use of the medium.... We plated 3,815 rectal swabs to the Spectra VRE agar and compared results to traditional identification and susceptibility testing.... Dark blue or purple colonies on the agar demonstrated a sensitivity of 98% and specificity of 85% for detection of VRE faecium, but light blue colonies were significantly less specific for E. faecalis... We streamlined our workflow to accept dark blue or purple colonies as VRE faecium and plan to perform additional testing only on light blue colonies. Interestingly, higher quantity of growth increased...

In vitro activity and adaptation strategies of eravacycline in clinical Enterococcus faecium isolates from China.

Eravacycline (Erava) is a synthetic fluorocycline with potent antimicrobial activity against a wide range of Gram-positive bacteria. This study aimed to investigate the in vitro antimicrobial activity...

Anticancer Effect of Enterococcus faecium, Isolated from Vaginal Fluid, on Ovarian Cancer Cells

Given the association between cervicovaginal microbiota and OVC, we investigated the effect of Enterococcus faecium conditioned medium (CM) on OVC (Caov-4) cells.... CM was obtained from the bacterium E. faecium isolated from the vagina of healthy women. The Caov-4 cells were treated with varying concentrations of CM that comprised co-cultured bacteria with 0.2, 0... The CM at a concentration of 0.5 OD from the cultured bacteria and incubation time of 48 h showed the highest negative effect on the viability of cancer cells. The CM treatment increased DNA fragmenta... CM of human-derived E. faecium could have an anticancer effect on OVC cells in a concentration- and time-dependent manner. This study demonstrated that E. faecium secretes anticancer substances into t...

Efficacy of teicoplanin in bloodstream infections caused by Enterococcus faecium: posthoc analysis of a nationwide surveillance.

Vancomycin and teicoplanin are glycopeptides with activity against Enterococcus faecium. However, studies on the clinical efficacy of teicoplanin are limited. This study aimed to compare the therapeut... We identified patients with bloodstream infections prospectively from July 2015 to December 2016 in 14 hospitals as part of a multicenter nationwide surveillance. Patients with E. faecium monomicrobia... Among 97 patients with E. faecium bacteremia, 33 (34%) were treated with teicoplanin and 64 (66%) with vancomycin. There were no significant differences in 30-day in-hospital mortality (18.2% vs 26.6%... We found no significant differences in the clinical outcomes. These findings suggest teicoplanin as a useful alternative to vancomycin....

Dissemination of Quinupristin-Dalfopristin and Linezolid resistance genes among hospital environmental and healthy volunteer fecal isolates of Enterococcus faecalis and Enterococcus faecium.

Streptogramins and linezolid are important in the treatment of infections caused by vancomycin-resistant enterococci.... Then, we aimed to evaluate the resistance rates against these drugs and the prevalence of genes involved in hospital environmental and fecal normal-flora isolates of Enterococcus faecalis and Enteroco... The strains were isolated from the stool samples and hospital environments by culturing on M-Enterococcus (ME) agar, and identified by phenotypic and genotypic microbiological tests. The disk agar dif... High-level streptogramin resistance rate and high prevalence of resistance genes in enterococci isolated from the stool of healthy persons and the hospital environment indicates the importance of poss...

Genome analysis of multidrug resistant Enterococcus faecium and Enterococcus faecalis circulating among hospitalized patients in uMgungundlovu District, KwaZulu-Natal, South Africa.

Vancomycin-resistant enterococci (VRE) are important pathogens categorized as high-priority bacteria in the Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Deve... A cross-sectional study was conducted during a two-month periods among hospitalized patients in 2017. Rectal swabs were collected from patients admitted to medical and surgical wards in an urban terti... Sequencing analysis revealed that these strains harbouring numerous resistance genes to glycopeptides (vanC[100%], vex3[100%], vex2[83,33%] and vanG[16,66%]), macrolides, lincosamides, sterptogramine ... The study reveals the genetic diversity and high pathogenicity of multidrug-resistant Enterococcus faecalis and faecium circulating among hospitalized patients. It underlines the necessity to implemen...

Evolution of Enterococcus faecium in Response to a Combination of Daptomycin and Fosfomycin Reveals Distinct and Diverse Adaptive Strategies.

Infections caused by vancomycin-resistant Enterococcus faecium (VREfm) are an important public health threat. VREfm isolates have become increasingly resistant to the front-line antibiotic daptomycin ...